24 results
8-K
EX-1.1
TPST
Tempest Therapeutics, Inc.
20 Jun 24
Tempest Unveils New Survival Data for Amezalpat (TPST-1120) in Randomized First-Line HCC Study Demonstrating a Six-Month Improvement over Control Arm
8:13am
by the Company of the Shares.
(rr) Cybersecurity. The Company’s and its subsidiaries’ information technology assets and equipment, computers, systems, networks
8-K
EX-10.1
nr7p5
2 May 22
Tempest Announces Private Placement Financing of $15 Million
8:02am
PRE 14A
t29 f08ekb8wi
22 Apr 22
Preliminary proxy
4:01pm
8-K
EX-1.1
0kokyxfauvec4u4bbf
23 Jul 21
Other Events
5:20pm
8-K
EX-99.2
f0mom6
16 Jul 21
Other Events
4:31pm